Welcome to our dedicated page for PEGASYSTEMS SEC filings (Ticker: PEGA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Pegasystems Inc. filings document regulatory disclosures for a Massachusetts software company whose business centers on AI-powered enterprise transformation, workflow automation, customer engagement, and legacy-system modernization. Current 8-K reports record quarterly and annual financial results, Pega Cloud and Annual Contract Value metrics, share repurchase authorization updates, exit and disposal activity costs, and litigation-related events.
Proxy materials disclose board matters, executive compensation, equity awards, pay-versus-performance data, and shareholder voting items. Other current reports describe executive incentive compensation plans and governance actions tied to the company's operating and capital-allocation framework.
PEGASYSTEMS INC (PEGA) senior vice president and chief accounting officer Efstathios A. Kouninis reported multiple equity transactions. On August 31, 2026 he exercised options for 2,500 shares at $16.95 per share, with 1,488 shares delivered or withheld to cover the exercise price or tax obligations and 1,012 shares sold at $36.50 per share. On September 1, 2026, 206 restricted stock units converted into common stock, with 51 shares delivered or withheld to cover obligations at $36.81 per share. After these transactions, he continues to hold 9,300 options and 412 restricted stock units, and the transactions are not reported as made under a Rule 10b5-1 trading plan.
PEGASYSTEMS INC (PEGA) received a Rule 144 notice from officer Efstathios A. Kouninis covering a proposed sale of 1,012 shares of common stock on 08/31/2026, to be issued via exercise of options under a registered plan. The filing also lists several smaller open-market sales in the prior three months.
PEGASYSTEMS INC (PEGA) reported that Chief Product Officer Rifat Kerim Akgonul sold a total of 3,000 shares of common stock on 2026-08-25. The sales were reported as open-market or private transactions at prices of $33.9801 and $34.00 per share. Post-transaction share holdings were not reported in this filing.
PEGASYSTEMS INC (PEGA) director Dianne Ledingham reported an internal reallocation of holdings through bona fide gift transactions dated 2026-08-25. She transferred 6,242 shares of common stock from her direct ownership to the Dianne Ledingham Family Legacy Trust. Her directly held shares decreased to 0, while the trust’s indirect holdings increased to 40,280 shares. The reported gifts were at a stated price of $0.00 per share.
PEGASYSTEMS INC (PEGA) received a Rule 144 notice from officer Rifat Kerim Akgonul covering a planned sale of its common stock. The notice lists up to 3,000 shares of common stock, arising from previously exercised options, to be sold for cash, with an indicated aggregate market value of $101,966.10. The securities are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services and are listed on NASDAQ.
PEGASYSTEMS INC (PEGA) director Larry Weber reported equity compensation awards for his annual board term. He received 3,868 shares of unrestricted common stock as director consideration, increasing his direct common stock holdings to 14,500 shares. He was also granted a fully vested non-statutory stock option for 7,947 shares of common stock at an exercise price of $32.32 per share, expiring on August 15, 2036, also as consideration for his director service.
PEGASYSTEMS INC (PEGA) director Sharon T. Rowlands reported equity awards for board service. On 2026-08-15, she received 3,868 shares of unrestricted common stock as consideration for her annual director term. The same day, she was granted a non-statutory stock option for 7,947 shares of common stock, fully vested on issuance, with an exercise price of $32.32 per share and an expiration date of 2036-08-15. Following these awards, she directly holds 3,868 common shares and the reported option, and indirectly holds 67,730 common shares through the “Sharon T. Rowlands Living Trust u/a/d 01/03/2020.”
PEGASYSTEMS INC (PEGA) director Dianne Ledingham reported equity awards related to her board service. She received 3,868 shares of unrestricted common stock on August 15, 2026 as consideration for her annual term as a director, increasing her directly held common stock to 6,242 shares. On the same date, she was also granted a non-statutory stock option covering 7,947 shares of common stock at an exercise price of $32.32 per share, fully vested on issuance and expiring August 15, 2036. In addition to these direct holdings, 34,038 shares of common stock are held indirectly through the Dianne Ledingham Family Legacy Trust.
PEGASYSTEMS INC (PEGA) reported that Director Christopher LaFond received equity awards as compensation for his annual board term. He acquired 3,868 shares of unrestricted common stock and a fully vested non-statutory stock option for 7,947 shares at an exercise price of $32.32 per share, expiring on August 15, 2036. Following these awards, he directly holds 25,548 shares of common stock.
PEGASYSTEMS INC (PEGA) director Richard H. Jones reported compensation-related equity awards. On 2026-08-15 he received 3,868 shares of unrestricted common stock as consideration for his annual director service and a fully vested non-statutory stock option for 7,947 shares at an exercise price of $32.32, expiring 2036-08-15. The filing also lists indirect holdings of common stock through several family trusts.